The Nuvigil and Provigil Pregnancy Registry

NCT01792583 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 191

Last updated 2024-02-05

No results posted yet for this study

Summary

The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during pregnancy.

Conditions

Interventions

DRUG

Modafinil/armodafinil

Sponsors & Collaborators

  • Cephalon, Inc.

    lead INDUSTRY

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01792583 on ClinicalTrials.gov